BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2995870)

  • 1. [Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests].
    Gorini M; Ghizzi A; Carlo Stella C; De Caro L
    Minerva Med; 1985 Sep; 76(37):1663-75. PubMed ID: 2995870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anomalous glucose and insulin responses in patients with insulinoma. Caveats for diagnosis.
    Dons RF; Hodge J; Ginsberg BH; Brennan MF; Cryer PE; Kourides IA; Gorden P
    Arch Intern Med; 1985 Oct; 145(10):1861-3. PubMed ID: 2994586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma.
    van Bon AC; Benhadi N; Endert E; Fliers E; Wiersinga WM
    Neth J Med; 2009; 67(7):274-8. PubMed ID: 19687521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypoglycemia: clarification and etiology].
    Keller U
    Schweiz Med Wochenschr; 1980 Mar; 110(13):495-8. PubMed ID: 6246574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin surrogates in insulinoma.
    O'Brien T; O'Brien PC; Service FJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):448-51. PubMed ID: 8345050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.
    Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J
    Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tolbutamide plus somatostatin test in the diagnosis of insulinomas].
    Jara Albarrán A; Caballero Asensi A; García Peris P; Coste A; Toledano E; Gorospe C; Caviola E; Palacios Mateos JM
    Rev Clin Esp; 1982 Jan; 164(2):105-9. PubMed ID: 6124027
    [No Abstract]   [Full Text] [Related]  

  • 8. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
    Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of insulinomas--analysis of 6 cases].
    Yang JZ
    Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):389-91. PubMed ID: 2559838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulinoma. Apropos of a new case].
    Cotano Urrutikoetxea JR; Madariaga Vidal MA; Pérez San José C; Sabas Olabarría JA; Barrallo Villar G; Duque de las Heras C
    Rev Esp Enferm Apar Dig; 1989 Sep; 76(3):285-9. PubMed ID: 2554432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts in diagnosis of insulinoma.
    Alsever RN; Stjernholm MR
    Rocky Mt Med J; 1974 Apr; 71(4):209-12. PubMed ID: 4362645
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
    Ueda K; Kawabe K; Lee L; Tachibana Y; Fujimori N; Igarashi H; Oda Y; Jensen RT; Takayanagi R; Ito T
    Pancreas; 2017 Apr; 46(4):476-481. PubMed ID: 28230660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pancreatic islet of infants with severe hypoglycemia.
    Misugi K; Misugi N; Sotos J; Smith B
    Arch Pathol; 1970 Mar; 89(3):208-20. PubMed ID: 4906256
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of artificial beta cell in diagnosis and treatment of insulinoma.
    Raptis S; Zoupas C; Dimitriadis G; Moulopoulos S
    Horm Metab Res Suppl; 1979; (8):169-72. PubMed ID: 231567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of glucose utilization in patients with insulin-independent diabetes mellitus by using breathing test].
    Ziakun AM; Maevskiĭ EI; Sokolov EI; Starkova NT; Davydov AL; Grishina EV; Kudriavtseva AI; Zakharchenko VN; Peshenko VP; Shidlovskiĭ M
    Biofizika; 2004; 49(5):948-57. PubMed ID: 15526484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinoma: how reliable is the biochemical evidence?
    Chammas NK; Teale JD; Quin JD
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):689-93. PubMed ID: 14629810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinoma.
    Halder PJ; Hafeezunnisa P; Pai R; Samsi AB
    J Postgrad Med; 1992; 38(4):202-4, 198. PubMed ID: 1307597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits].
    Xiang K; Fang Q; Zheng T; Jia W; Wang Y; Zhang R; Li J; Shen K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):426-30. PubMed ID: 11774208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative localization and intraoperative glucose monitoring in the management of patients with pancreatic insulinoma.
    Katz LB; Aufses AH; Rayfield E; Mitty H
    Surg Gynecol Obstet; 1986 Dec; 163(6):509-12. PubMed ID: 3024340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma.
    Pun KK; Young RT; Wang C; Tam CF; Ho PW
    J Clin Endocrinol Metab; 1988 Sep; 67(3):546-50. PubMed ID: 2842361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.